AINGX
Price
$10.59
Change
-$0.00 (-0.00%)
Updated
Nov 14 closing price
PRNPX
Price
$10.03
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

AINGX vs PRNPX

Header iconAINGX vs PRNPX Comparison
Open Charts AINGX vs PRNPXBanner chart's image
American Century Inflation-Adjs Bond G
Price$10.59
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
PIMCO Real Return I-3
Price$10.03
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
AINGX vs PRNPX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AINGX vs. PRNPX commentary
Nov 15, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AINGX is a Hold and PRNPX is a Hold.

FUNDAMENTALS
Fundamentals
PRNPX has more cash in the bank: 7.6B vs. AINGX (2.47B). AINGX pays higher dividends than PRNPX: AINGX (4.92) vs PRNPX (3.04). AINGX was incepted earlier than PRNPX: AINGX (7 years) vs PRNPX (7 years). PRNPX is a more actively managed with annual turnover of: 71.00 vs. AINGX (18.00). AINGX has a lower initial minimum investment than PRNPX: AINGX (0) vs PRNPX (1000000). PRNPX (6.26) and AINGX (6.07) have marching annual gain over last year. AINGX (11.65) and PRNPX (11.55) have equivalent 5 years return.
AINGXPRNPXAINGX / PRNPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years7 years-
Gain YTD2.5612.93187%
Front LoadN/AN/A-
Min. Initial Investment01000000-
Min. Initial Investment IRAN/AN/A-
Net Assets2.47B7.6B33%
Annual Yield % from dividends4.923.04162%
Returns for 1 year6.076.2697%
Returns for 3 years-6.85-6.61104%
Returns for 5 years11.6511.55101%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XPON3.380.09
+2.58%
Expion360 Inc
ZGN7.650.14
+1.86%
Ermenegildo Zegna NV
TPB55.00N/A
N/A
Turning Point Brands
STE222.27-0.46
-0.21%
STERIS plc
INZY3.55-0.21
-5.59%
Inozyme Pharma